Protein oxidation in the brain in Alzheimer's disease

In this study we used immunohistochemistry and two-dimensional fingerprinting of oxidatively modified proteins (two-dimensional Oxyblot) together to investigate protein carbonyl formation in the Alzheimer's disease brain. Increased protein oxidation was detected in sections from the hippocampus and parahippocampal gyrus, superior and middle temporal gyri of six Alzheimer's disease and six age-matched control human subjects, but not in the cerebellum. In two brain regions severely affected by Alzheimer's disease pathology, prominent protein carbonyl immunoreactivity was localized in the cytoplasm of neurons without visual pathomorphological changes and degenerating neurons, suggesting that intracellular proteins might be significantly affected by oxidative modifications. Following two-dimensional electrophoresis the positions of some individual proteins were identified using specific antibodies, and immunoblot analysis for protein carbonyls was performed. These studies demonstrated the presence of protein carbonyl immunoreactivity in beta-tubulin, beta-actin and creatine kinase BB in Alzheimer's disease and control brain extracts. Protein carbonyls were undetectable in spots matching glial fibrillary acidic protein and tau isoforms. Specific protein carbonyl levels in beta-actin and creatine kinase BB were significantly higher in Alzheimer's disease than in control brain extract. beta-Tubulin did not demonstrate a significant increase in specific protein carbonyl content in Alzheimer's disease brains. We suggest that oxidative stress-induced injury may involve the selective modification of different intracellular proteins, including key enzymes and structural proteins, which precedes and may lead to the neurofibrillary degeneration of neurons in the Alzheimer's disease brain.

[1]  P. Riederer,et al.  Free radicals in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[2]  J. Trojanowski,et al.  Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). , 1992, Laboratory investigation; a journal of technical methods and pathology.

[3]  S. Yen,et al.  An immunochemical study on tau glycation in paired helical filaments , 1999, Brain Research.

[4]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[5]  R. Dean,et al.  Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.

[6]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[7]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[8]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[9]  M. Tabaton,et al.  Is amyloid β‐protein glycated in Alzheimer's disease? , 1997 .

[10]  Steven A. Johnson,et al.  Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress , 1995, Experimental Neurology.

[11]  J. Goldman.  Immunocytochemical studies of actin localization in the central nervous system , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  J. Carney,et al.  The Expression of Creatine Kinase Isoenzymes in Neocortex of Patients with Neurodegenerative Disorders: Alzheimer's and Pick's Disease , 1997, Experimental Neurology.

[13]  E. Stadtman,et al.  Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.

[14]  R. W. Gracy,et al.  A double stain for total and oxidized proteins from two-dimensional fingerprints. , 1998, Analytical biochemistry.

[15]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[16]  M. Mattson,et al.  Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease‐Associated Amyloid Beta Peptide a , 1996, Annals of the New York Academy of Sciences.

[17]  K. Brunden,et al.  Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro , 1996, Neurobiology of Aging.

[18]  Y. Ando,et al.  Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid , 1998, Journal of the Neurological Sciences.

[19]  M. Tabaton,et al.  Is amyloid beta-protein glycated in Alzheimer's disease? , 1997, Neuroreport.

[20]  R. Colombo,et al.  Prolonged oxidative stress on actin. , 1997, Archives of biochemistry and biophysics.

[21]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[22]  D. Butterfield,et al.  3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease , 2000, Brain Research.

[23]  D. Butterfield,et al.  Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain , 2000, Journal of neurochemistry.

[24]  D. Butterfield,et al.  Aging in a dish: Age‐dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long‐term hippocampal cell culture , 1999, Journal of neuroscience research.

[25]  G. Sobue,et al.  Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. , 1997, Biochemical and biophysical research communications.

[26]  J. Remacle,et al.  Low levels of reactive oxygen species as modulators of cell function. , 1995, Mutation research.

[27]  A. Nakamura,et al.  Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. , 1996, Journal of biochemistry.

[28]  A. L. Watson,et al.  In vitro polymerization of oxidized tau into filaments , 1993, Brain Research.

[29]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Trojanowski,et al.  Oxidation of Cytosolic Proteins and Expression of Creatine Kinase BB in Frontal Lobe in Different Neurodegenerative Disorders , 1999, Dementia and Geriatric Cognitive Disorders.

[32]  J. Ávila,et al.  Analysis of microtubule-associated protein tau glycation in paired helical filaments. , 1994, The Journal of biological chemistry.

[33]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[34]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[35]  M. Beal,et al.  Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[37]  C. Behl.  Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches , 1999, Progress in Neurobiology.

[38]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[39]  W. Markesbery,et al.  Protein Oxidation in Aging Brain a , 1992, Annals of the New York Academy of Sciences.

[40]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[41]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[42]  D. Butterfield,et al.  Glutamine Synthetase‐Induced Enhancement of β‐Amyloid Peptide Aβ(1–40) Neurotoxicity Accompanied by Abrogation of Fibril Formation and Aβ Fragmentation , 1996 .

[43]  M. Mattson,et al.  Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. , 1996, Molecular neurobiology.

[44]  D. Allan Butterfield,et al.  Chapter 7 Protein Oxidation Processes in Aging Brain , 1997 .

[45]  L. Chang,et al.  Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease , 1995, Neurology.

[46]  R. S. Sohal,et al.  Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[48]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[50]  H. Kamata,et al.  Redox regulation of cellular signalling. , 1999, Cellular signalling.

[51]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[52]  D. Tuma,et al.  Acetaldehyde and Microtubules a , 1991, Annals of the New York Academy of Sciences.

[53]  K. Yasuda,et al.  Carbonylated proteins in aging and exercise: immunoblot approaches , 1999, Mechanisms of Ageing and Development.

[54]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.